glp-1 nad Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP-1 Medications Show Promise as
Description
Improvement of Glucose Tolerance by Food Factors Having Glucagon-Like Peptide-1 Releasing Activity
GLP-1 agonists may lessen your, ahem, thirst while dialing back hunger
Lim H, Devesa SS, Sosa JA, et al
However, these technologies are years away from potential approval for human use
